Company page

Bionime Corporation

Bionime Corporation, trading under the ticker 4737 on the Taiwan market, has a market capitalization of approximately 143.31 million USD. The company specializes in developing and manufacturing medical devices, particularly focusing on blood glucose monitoring systems. Bionime aims to enhance diabetes management through innovative technology and reliable products.